- By ICR Secretariat
- Posted Monday, September 5, 2022
US earmarks up to $680M for Chimerix's smallpox drug Tembexa, clearing way for Emergent buyout
During the latest monkeypox outbreak, doctors in the U.S. have been treating patients with Siga Technologies’ smallpox drug Tpoxx. Now, the U.S. government may have a second potential antiviral option at its disposal.